IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Medicxi Ventures Management (Jersey) Ltd

Q4 2022 Holdings

Filed 2023-01-31 | 6 holdings | $238.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vaxcyte Inc(PCVX)COM92243G108$69.9M1,457,30029.3%
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$61.9M19,963,15726.0%
Aura Biosciences Inc(AURA)COM05153U107$31.9M3,039,89213.4%
Phathom Pharmaceuticals Inc(PHAT)COM71722W107$27.9M2,484,27411.7%
Merus N VCOMN5749R100$24.8M1,600,00010.4%
Newamsterdam Pharma Company(NAMS)ORDINARY SHARESN62509109$21.8M2,000,0009.2%